Skip to the page

Data / Medical devices / United States / Revance Therapeutics, Inc.

Revance Therapeutics, Inc.: FDA-registered device maker in Newark, CA, United States, 1 PMA approval

Revance Therapeutics, Inc. is registered with the FDA (registration 3007772056) in Newark, CA, United States. It lists 1 device type. The FDA files 1 PMA approval under its listings, the newest dated October 19, 2017. Registered through 2027. FDA data exported November 2, 2026.

SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.

FDA registration number
3007772056
Address
7555 Gateway Blvd, Newark, CA, United States, 94560
Owner or operator
Revance Therapeutics, Inc. (10062439)
Roles
Complaint file establishment
First device listed
August 30, 2024
Registered through
2027
Brand names listed
RHA Redensity® Eye, RHA® 2; RHA® 2 Mepi; RHA® 3; RHA® 3 Mepi; RHA® 4; RHA® 4 Mepi; RHA® Dynamic Volume; RHA® Redensity; RHA® Redensity Mepi

Devices it lists

DeviceProduct codeClassRoleSource
Implant, Dermal, For Aesthetic UseLMH3Complaint file establishmentaccessdata.fda.gov

PMA approvals

Premarket approvals this establishment lists, with the supplements the FDA has decided since.

ApprovedPMA numberDeviceProduct codeSupplementsLatest decisionSource
October 19, 2017P170002RHA 2, RHA 3, RHA 4LMH55August 31, 2026accessdata.fda.gov

Compare with other makers

Updated August 31, 2026. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.